Brief: Onxeo Partners With Gustave Roussy In Clinical Trial Of AsiDNA Cancer Treatment
Jan 29 (Reuters) - Onxeo SA C4X.PA :
* ONXEO ENTERS CLINICAL RESEARCH AGREEMENT WITH GUSTAVE
ROUSSY TO
CONDUCT CLINICAL TRIAL OF ASIDNA FOR TREATMENT OF RELAPSED
OVARIAN
* AIM TO START ENROLLING PATIENTS IN THE FIRST SEMESTER OF
2020
AND OBTAIN PRELIMINARY RESULTS BEFORE YEAR-END
Source text for Eikon: ID:nBw7PvHWya
Further company coverage: C4X.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln